Table 1 Baseline characteristics.
Demographics and baseline characteristics | Overall patients (N = 47) |
|---|---|
Median age (range), years | 61 (37–83) |
Female; n(%) | 28 (59.6) |
Race [n (%)] | |
Black or African American | 2 (4.3) |
Asian | 10 (21.3) |
Native Hawaiian or Other Pacific Islander | 1 (2.1) |
White | 34 (72.3) |
ECOG PS; n(%) | |
0 | 31 (66) |
1 | 16 (34) |
Median Time Since Initial Diagnosis(range), years | 2.11 (0.3–14.4) |
Tumor type; n(%) | |
Melanoma | 12 (25.5) |
Colorectal cancer | 10 (21.3) |
Non-small cell lung cancer | 4 (8.5) |
Triple negative breast cancer | 3 (6.4) |
Esophageal squamous cell carcinoma | 3 (6.4) |
Gastric cancer | 3 (6.4) |
Other | 12 (25.5) |
Prior CPI therapy; n (%) | 20 (42.6) |
anti-PD-(L)1 only | 18 (38.3) |
anti-PD-(L)1+anti-CTLA-4 | 2 (4.3) |
Prior cancer-related surgery; n (%) | 41 (87.2) |
Prior radiotherapy; n (%) | 32 (68.1) |
Prior lines of systemic therapy; n (%) | |
0 | 1 (2.1) |
1–2 | 25 (53.2) |
≥3 | 21 (44.7) |
